SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,180,209.38070502. The last known price of Ethereum is 2,270.17304981 USD and is up 0.59 over the last 24 hours. It is currently trading on 14230 active market(s) with $5,193,092,001.43 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a crypto-wide selloff that traders link to the reported multibillion-dollar Binance hack, raising concerns about exchange security, trust and potential outflows. Reactions are split: some view the weakness as a buying opportunity and cite Binances claims that customer funds are covered, while others warn of further downside.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY discussion centers on a sharp selloff followed by a volatile rebound, which traders associate with falling oil and hopes for U.S.-Iran de-escalation ahead of midterms. Bulls are buying the dip and anticipating more gains, while skeptics call the bounce a trap and point to AI-related tech weakness and lingering geopolitical uncertainty.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure after a sharp tech selloff tied to disappointing big-tech earnings and renewed concerns that heavy AI spending may not translate into sustainable returns. Traders are divided between expecting an oversold rebound and warning that the technical breakdown could bring more downside, while Iran and oil headlines add to volatility.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs upcoming quarterly report is the main focus, with traders debating whether results and forward guidance can clear already-high expectations. Bulls point to AI demand and growth, while skeptics warn that the stocks rich valuation and a broader pullback in AI shares could leave it vulnerable even if results are strong.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Semiconductor stocks are selling off amid concerns that heavy AI and data-center spending may not generate returns quickly enough, with Intels weak outlook and broader tech deleveraging adding pressure. Traders are divided between viewing the drop as a sign the AI trade is faltering and treating it as an oversold pullback while chip demand remains strong.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

The FDAs accelerated approval of Inovios competing RRP treatment has raised concerns about competition for Precigens PAPZIMEOS. Traders are divided over the threat, weighing the rivals treatment approach against Precigens first-mover commercial traction and full-approval status.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Reports that Marvell is in advanced talks to acquire Lumentum have fueled heavy selling and debate over the potential deals cost and financing, particularly shareholder dilution and added debt; the talks remain unconfirmed. Traders are split between seeing the move as a costly risk for shareholders and a strategic way to secure optical components for AI data centers, against a broader weak tape for tech stocks.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is drawing attention after a sharp semiconductor selloff, as traders reassess AI-related valuations and whether hyperscaler spending can generate sustainable returns; weak Intel results added to sector pressure. The community is split between fears of a deeper AI-trade correction and expectations of an oversold bounce near long-term technical support.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the upper-limb function data and the November 22 target date. New commercial and patient-services job postings are viewed by some as signs of launch preparations, while others caution that hiring does not confirm approval and debate the risk of a restricted label or rejection.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgos sharp, volatile swings are drawing attention, with traders debating whether recent momentum reflects a short squeeze and enthusiasm for its AI-powered autonomous-lab pivot or a pullback alongside speculative biotech shares. Bulls point to pharma and research partnerships as validation, while skeptics say weak results and limited evidence of paid demand leave the new business model unproven.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
